Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

A study on the association between infectious burden and Alzheimer's disease.

Bu XL, Yao XQ, Jiao SS, Zeng F, Liu YH, Xiang Y, Liang CR, Wang QH, Wang X, Cao HY, Yi X, Deng B, Liu CH, Xu J, Zhang LL, Gao CY, Xu ZQ, Zhang M, Wang L, Tan XL, Xu X, Zhou HD, Wang YJ.

Eur J Neurol. 2015 Dec;22(12):1519-25. doi: 10.1111/ene.12477. Epub 2014 Jun 9.

PMID:
24910016
2.

The association between infectious burden and Parkinson's disease: A case-control study.

Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, Liu CH, Deng B, Yao XQ, Xu ZQ, Zhou HD, Wang YJ.

Parkinsonism Relat Disord. 2015 Aug;21(8):877-81. doi: 10.1016/j.parkreldis.2015.05.015. Epub 2015 May 30.

PMID:
26037459
3.

Infection, inflammation and Alzheimer's disease.

Schott JM.

Eur J Neurol. 2015 Dec;22(12):1503-4. doi: 10.1111/ene.12522. Epub 2014 Jul 17. No abstract available.

PMID:
25039413
4.

Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Harris SA, Harris EA.

J Alzheimers Dis. 2015;48(2):319-53. doi: 10.3233/JAD-142853. Review.

5.

Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.

Sagare AP, Deane R, Zetterberg H, Wallin A, Blennow K, Zlokovic BV.

J Alzheimers Dis. 2011;24(1):25-34. doi: 10.3233/JAD-2010-101248.

6.

Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease.

Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, Schlumberger W, Meyer J; AutoGene Investigators..

Circulation. 2001 Jul 3;104(1):25-31.

7.

Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis.

Zhou L, Chan KH, Chu LW, Kwan JS, Song YQ, Chen LH, Ho PW, Cheng OY, Ho JW, Lam KS.

Biochem Biophys Res Commun. 2012 Jul 13;423(4):697-702. doi: 10.1016/j.bbrc.2012.06.017. Epub 2012 Jun 12.

PMID:
22704931
8.

Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients.

Tsirpanlis G, Chatzipanagiotou S, Ioannidis A, Boufidou F, Moutafis S, Nicolaou C.

Nephrology (Carlton). 2005 Jun;10(3):256-63.

PMID:
15958038
9.

The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.

Giedraitis V, Sundelöf J, Irizarry MC, Gårevik N, Hyman BT, Wahlund LO, Ingelsson M, Lannfelt L.

Neurosci Lett. 2007 Nov 12;427(3):127-31. Epub 2007 Sep 20.

PMID:
17936506
10.

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

Mehta PD, Pirttilä T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM.

Arch Neurol. 2000 Jan;57(1):100-5.

PMID:
10634455
11.

Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results.

Roubaud-Baudron C, Krolak-Salmon P, Quadrio I, Mégraud F, Salles N.

Neurobiol Aging. 2012 May;33(5):1009.e11-9. doi: 10.1016/j.neurobiolaging.2011.10.021. Epub 2011 Dec 1.

PMID:
22133280
12.

Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.

Takeda S, Sato N, Uchio-Yamada K, Yu H, Moriguchi A, Rakugi H, Morishita R.

Dement Geriatr Cogn Disord. 2012;34(1):25-30. doi: 10.1159/000338704. Epub 2012 Aug 9.

PMID:
22889768
13.

Association of pathogen burden and hypertension: the Persian Gulf Healthy Heart Study.

Vahdat K, Pourbehi MR, Ostovar A, Hadavand F, Bolkheir A, Assadi M, Farrokhnia M, Nabipour I.

Am J Hypertens. 2013 Sep;26(9):1140-7. doi: 10.1093/ajh/hpt083. Epub 2013 Jun 6.

PMID:
23744497
14.

Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.

Uslu S, Akarkarasu ZE, Ozbabalik D, Ozkan S, Colak O, Demirkan ES, Ozkiris A, Demirustu C, Alatas O.

Neurochem Res. 2012 Jul;37(7):1554-9. doi: 10.1007/s11064-012-0750-0. Epub 2012 Mar 22.

PMID:
22437436
15.

Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system.

Konno T, Hata S, Hamada Y, Horikoshi-Sakuraba Y, Nakaya T, Saito Y, Yamamoto T, Yamamoto T, Maeda M, Ikeuchi T, Gandy S, Akatsu H, Suzuki T; Japanese Alzheimer's Disease Neuroimaging Initiative..

Mol Neurodegener. 2011 Nov 8;6:76. doi: 10.1186/1750-1326-6-76.

16.

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

Wang T, Xiao S, Liu Y, Lin Z, Su N, Li X, Li G, Zhang M, Fang Y.

Int J Geriatr Psychiatry. 2014 Jul;29(7):713-9. doi: 10.1002/gps.4053. Epub 2013 Dec 7.

PMID:
24318929
17.

Impact of infectious burden on extent and long-term prognosis of atherosclerosis.

Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J; AtheroGene Investigators..

Circulation. 2002 Jan 1;105(1):15-21.

18.

β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.

Bourgade K, Garneau H, Giroux G, Le Page AY, Bocti C, Dupuis G, Frost EH, Fülöp T Jr.

Biogerontology. 2015 Feb;16(1):85-98. doi: 10.1007/s10522-014-9538-8. Epub 2014 Nov 7.

PMID:
25376108
19.

Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases.

Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS.

Stroke. 2003 Sep;34(9):2126-31. Epub 2003 Aug 14.

20.

Cognitive impairment and infectious burden in the elderly.

Strandberg TE, Pitkala KH, Linnavuori K, Tilvis RS.

Arch Gerontol Geriatr Suppl. 2004;(9):419-23.

PMID:
15207442

Supplemental Content

Support Center